reports
BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis i...
BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting –Presentations will demonstrate high adherence and persistence, sustained attack reductions and patient preference for oral, once-daily ORLADEYO for hereditary angioedema– RESEARCH TRIANGLE PARK, N.C., Oct. 10, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced that the company will present four abstracts on oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment o...
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtua...
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit WESTLAKE VILLAGE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that , President, CEO and Chairman of the Board, will participate at the 2024 Maxim Healthcare Virtual Summit taking place October 15-17, 2024. Mr. Zindrick will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat with Jason McCarthy, Ph.D., Senior Managing Director, Head of Biotechnology Research, which is scheduled for 2:00 p...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
OCUL OCULAR THERAPEUTIX
HNRG HALLADOR ENERGY CO.
EAT BRINKER INTERNATIONAL INC.
DECK DECKERS OUTDOOR CORPORATION
CSIQ CANADIAN SOLAR INC.
COLL COLLEGIUM PHARMACEUTICAL INC.
CALM CAL-MAINE FOODS INC.
CAKE CHEESECAKE FACTORY INCORPORATED
BBW BUILD-A-BEAR WORKSHOP
ASPN ASPEN AEROGELS
APOG APOGEE ENTERPRISES INC.
AMSC AMERICAN SUPERCONDUCTOR CORP.
ALB ALBEMARLE CORPORATION
AAOI APPLIED OPTOELECTRONICS INC.
COF CAPITAL ONE FINANCIAL CORPORATION
ZUMZ ZUMIEZ INC.
VFC V.F. CORPORATION
CRVS CORVUS PHARMACEUTICALS
DESP DESPEGAR.COM CORP.
FNKO FUNKO CLASS A
AMD ADVANCED MICRO DEVICES INC.
ACMR ACM RESEARCH
PPIH PERMA PIPE INTERNATIONAL HOLDINGS
GLOB GAZIT-GLOBE LTD.
PLMR PALOMAR HOLDINGS
CAPR CAPRICOR THERAPEUTICS
CRMD CORMEDIX INC.
BILL BILL.COM HOLDINGS
ADPT ADAPTIVE BIOTECHNOLOGIES
GII SPDR S&P GLOBAL INFRASTRUCTURE
TVTX TRAVERE THERAPEUTICS INC
VHI VALHI INC.
ALKT ALKAMI TECHNOLOGY INC
SOFI SOFI TECHNOLOGIES INC
EVGO EVGO INC
ENVX ENOVIX CORP
TSE TRINSEO PLC
ASTS AST SPACEMOBILE INC
PLL PIEDMONT LITHIUM INC
MLTX MOONLAKE IMMUNOTHERAPEUTICS
EWTX EDGEWISE THERAPEUTICS INC
FTAI FORTRESS TRANSN & INFRAS INVS LLC
RDW REDWIRE CORP
COYA COYA THERAPEUTICS INC
SKWD SKYWARD SPECIALTY INS GROUP INC
MLYS MINERALYS THERAPEUTICS INC
ELVN IMARA INC
WGS GENEDX HOLDINGS CORP.
KGS KODIAK GAS SERVICES INC
BYRN BYRNA TECHNOLOGIES INC
NMRA NEUMORA THERAPEUTICS INC
ATGL ALPHA TECHNOLOGY GROUP LTD
NGNE NEUROGENE INC
DAVE DAVE INC
LENZ LENZ THERAPEUTICS INC
IBTA IBOTTA INC
FIP FTAI INFRASTRUCTURE INC
CLMT CALUMET INC
NUTX NUTEX HEALTH INC
DOGZ DOGNESS INTERNATIONAL CORP
TECX TD GLOBAL TECHNOLOGY LEADERS CAD HEDGED INDEX ETF
TBNK TD CANADIAN BANK DIVIDEND INDEX ETF
RDDT REDDIT INC
Humacyte Late-Breaking Abstract Accepted for Oral Presentation on V007...
Humacyte Late-Breaking Abstract Accepted for Oral Presentation on V007 Phase 3 AV Access Clinical Trial at the American Society of Nephrology’s Kidney Week 2024 DURHAM, N.C., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced that its late-breaking abstract on the V007 Phase 3 clinical trial of the acellular tissue engineered vessel (ATEV™) in arteriovenous access for patients with end-stage renal disease was accepted for an oral prese...
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
MOFG MIDWESTONE FINANCIAL GROUP
MEI METHODE ELECTRONICS INC.
KVHI KVH INDUSTRIES INC.
HNRG HALLADOR ENERGY CO.
I3N CHART INDUSTRIES INC.
GDOT GREEN DOT CORPORATION CLASS A
CRMT AMERICA'S CAR-MART INC.
CODI COMPASS DIVERSIFIED HOLDINGS
CDXS CODEXIS
AHH ARMADA HOFFLER PROPERTIES INC.
NEWT NEWTEK BUSINESS SERVICES INC.
A0JMXQ INDIA CAPITAL GROWTH FUND LTD.
CULP CULP INC.
ORN ORION GROUP HOLDINGS
AEHR AEHR TEST SYSTEMS
APTV APTIV PLC
JEF JEFFERIES FINANCIAL GROUP INC.
NANX NANOPHASE TECHNOLOGIES CORP.
AXR AMREP
ETON ETON PHARMACEUTICALS
STIM STIMSONITE CORP
INMB INMUNE BIO
NFE INC.
GCI NEW FORTRESS ENERGY
CAPR GANNETT CO. INC.
EPSN CAPRICOR THERAPEUTICS
FBIO EPSILON ENERGY LIMITED
WSC FABIEN CORP
VRDN WILLSCOT MOBILE MINI HOLDINGS CORP
CTLP VIRIDIAN THERAPEUTICS INC
SMMT CANTALOUPE
PFBX INC.
BMEA SUMMIT THERAPEUTICS INC
PCT PEOPLES FINANCIAL CORP. (MISSISSIPPI)
ASLE BIOMEA FUSION
BHVN INC.
BIGZ PURECYCLE TECHNOLOGIES INC
BUKS AERSALE CORP
ECBK BIOHAVEN LTD
CDIO BLACKROCK INNOVATION AND GROWTH TST
GTE BUTLER NATIONAL CORP
CRBP ECB BANCORP INC.
BMEZ CARDIO DIAGNOSTICS HLDGS INC
ASGI GRAN TIERRA ENERGY INC.
SYRS CORBUS PHARMACEUTICALS HOLDINGS INC.
XPER BLACKROCK HEALTH SCIENCES TERM TRUST
OMIC ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
PMN SYROS PHARMACEUTICALS INC.
BNTC XPERI INC
CLNN SINGULAR GENOMICS SYSTEMS INC
BNZI PROMIS NEUROSCIENCES INC.
BENITEC BIOPHARMA INC
CLENE INC
BANZAI INTERNATIONAL INC
Humacyte Announces Pricing of $30.0 Million Registered Direct Offering
Humacyte Announces Pricing of $30.0 Million Registered Direct Offering DURHAM, N.C., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that it entered into a securities purchase agreement with an institutional investor to purchase approximately $30.0 million worth of its common stock and warrants in a registered direct offering. Under the terms of the securities purchase agreement, the Company has agreed to sell 5,681,820 share...
- Jonathan Moreland
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4...
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 21 newly-hired employees stock options to purchase an aggregate of 71,175 shares, and restricted stock units (RSUs) covering an aggregate of 50,025 shares, of BioCryst common stock. The options and RSUs were granted as of September 30, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were grante...
BioCryst Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK...
BioCryst Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK5 Inhibitor, for the Treatment of Netherton Syndrome —Potential best-in-class targeted treatment for Netherton syndrome is company’s first protein therapeutic to advance to the clinic— —Initial data from trial expected by end of 2025— RESEARCH TRIANGLE PARK, N.C., Oct. 02, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced the enrollment of the first participant in a Phase 1 trial evaluating BCX17725, a potent and selective investigational kallikrein 5 (KLK5) inhibitor designed to provide best-in-class d...
U.S. Government Awards BioCryst $69 Million RAPIVAB® (peramivir inject...
U.S. Government Awards BioCryst $69 Million RAPIVAB® (peramivir injection) Contract for Strategic National Stockpile RESEARCH TRIANGLE PARK, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced that the U.S. Department of Health and Human Services (HHS) has awarded BioCryst up to a $69 million contract for the procurement of up to 95,625 doses over a five-year period of RAPIVAB® (peramivir injection) for the treatment of influenza. The contract, awarded by the HHS Office of the Administration for Strategic Preparedness and Response (ASPR), will supply the Center for...
- Jonathan Moreland
KVHI KVH INDUSTRIES INC.
HNRG HALLADOR ENERGY CO.
I3N CHART INDUSTRIES INC.
CTRN CITI TRENDS INC.
CRMT AMERICA'S CAR-MART INC.
CODI COMPASS DIVERSIFIED HOLDINGS
CDXS CODEXIS
NEWT NEWTEK BUSINESS SERVICES INC.
A0JMXQ INDIA CAPITAL GROWTH FUND LTD.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
HTLD HEARTLAND EXPRESS INC.
ORN ORION GROUP HOLDINGS
AEHR AEHR TEST SYSTEMS
APTV APTIV PLC
CLAR CLARUS CORPORATION
JEF JEFFERIES FINANCIAL GROUP INC.
NANX NANOPHASE TECHNOLOGIES CORP.
AXR AMREP
ETON ETON PHARMACEUTICALS
STIM STIMSONITE CORP
GCI GANNETT CO. INC.
CAPR CAPRICOR THERAPEUTICS
EPSN EPSILON ENERGY LIMITED
FBIO FABIEN CORP
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
VRDN VIRIDIAN THERAPEUTICS INC
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
BASE COUCHBASE
FTHY INC.
PCT FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
AMLX PURECYCLE TECHNOLOGIES INC
ASLE AMYLYX PHARMACEUTICALS INC
BHVN AERSALE CORP
BUKS BIOHAVEN LTD
ECBK BUTLER NATIONAL CORP
VEEE ECB BANCORP INC.
CDIO TWIN VEE POWERCATS CO
GTE CARDIO DIAGNOSTICS HLDGS INC
CRBP GRAN TIERRA ENERGY INC.
BMEZ CORBUS PHARMACEUTICALS HOLDINGS INC.
BNZI BLACKROCK HEALTH SCIENCES TERM TRUST
BTSG BANZAI INTERNATIONAL INC
ASGI BRIGHTSPRING HEALTH SERVICES INC.
SYRS ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
PEO SYROS PHARMACEUTICALS INC.
XPER PETROLEUM & RESOURCES CORPORATION
OMIC XPERI INC
PMN SINGULAR GENOMICS SYSTEMS INC
PROMIS NEUROSCIENCES INC.
Humacyte to Host Virtual KOL Event to Discuss Case Studies on the Use ...
Humacyte to Host Virtual KOL Event to Discuss Case Studies on the Use of Acellular Tissue Engineered Vessel (ATEV™) in Vascular Trauma Treatment on September 30, 2024 DURHAM, N.C., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced it will host a virtual KOL event on Monday, September 30, 2024 at 8:00 AM ET. To register, . The event will feature Charles Fox, MD (University of Maryland School of Medicine), Rishi Kundi MD, RPVI, ...
- Jonathan Moreland
AOI Leads Industry with 1.6T OSFP DR8 LPO Technology at ECOC 2024
AOI Leads Industry with 1.6T OSFP DR8 LPO Technology at ECOC 2024 Company to demonstrate high-speed connectivity with the Optical Internetworking Forum SUGAR LAND, Texas, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Applied Optoelectronics Inc. (“AOI”) (NASDAQ: AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, telecom and fiber-to-the-home (FTTH) markets, is demonstrating its latest linear technology, the 1.6T OSFP DR8 LPO module, at the European Conference on Optical Communications (“ECOC”) 2024, setting a new level for high-speed netw...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
AAON AAON INC.
XHR XENIA HOTELS & RESORTS INC.
WLDN WILLDAN GROUP
TSLA TESLA INC
TPC TUTOR PERINI CORPORATION
STRL STERLING CONSTRUCTION COMPANY INC.
RYAM RAYONIER ADVANCED MATERIALS INC
RLJ RLJ LODGING TRUST
PYPL PAYPAL HOLDINGS INC
PWR QUANTA SERVICES INC.
POWL POWELL INDUSTRIES INC.
PLCE CHILDREN'S PLACE INC.
MTZ MASTEC INC.
MOD MODINE MANUFACTURING COMPANY
INN SUMMIT HOTEL PROPERTIES INC.
CLDT CHATHAM LODGING TRUST
AAOI APPLIED OPTOELECTRONICS INC.
DRI DARDEN RESTAURANTS INC.
ITT ITT INC.
AGX ARGAN INC.
TG TREDEGAR CORP.
PNRG PRIMEENERGY RESOURCES
TAYD TAYLOR DEVICES INC.
TPB TURNING POINT BRANDS
USLM U.S. LIME & MINERALS
WLFC WILLIS LEASE FINANCE CORP.
USAP UNIVERSAL STAINLESS & ALLOY PRODUCTS INC.
PK PARK HOTELS & RESORTS INC.
ROAD CONSTRUCTION PARTNERS
BELFA BEL FUSE INC. CL A
AXR AMREP
SITM SITIME
IESC IES HOLDINGS INC.
VRDN VIRIDIAN THERAPEUTICS INC
COMM BMO GLOBAL COMMUNICATIONS INDEX ETF
JXN JACKSON FINANCIAL INC
PCT PURECYCLE TECHNOLOGIES INC
COHR COHERENT CORP
MBC_w MASTERBRAND INC
CRVO CERVOMED INC
DAVE DAVE INC
SOC SABLE OFFSHORE CORP
FTCO FORTITUDE GOLD
DOGZ DOGNESS INTERNATIONAL CORP
Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancr...
Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™) - New U.S. patent covers the design and composition of the BVP - - Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a potential treatment for type 1 diabetes - DURHAM, N.C., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced the allowance of a U.S. Patent covering its...
BioCryst and the pan-Canadian Pharmaceutical Alliance (pCPA) Successfu...
BioCryst and the pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for ORLADEYO® (berotralstat), an Oral, Once-daily Therapy for the Prevention of Hereditary Angioedema Attacks INTENDED FOR CANADIAN AUDIENCES ONLY TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced that it successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for oral, once-daily PrORLADEYO® (berotralstat), which is approved in Canada for the routine prevention of attacks of hereditary angioedema (HAE) in adults and pediatric patients...
BioCryst et l’Alliance pharmaceutique pancanadienne concluent avec suc...
BioCryst et l’Alliance pharmaceutique pancanadienne concluent avec succès les négociations au sujet de ORLADEYO (bérotralstat), un traitement oral à prise uniquotidienne pour la prévention des crises d’angio-œdème héréditaire RÉSERVÉ À UN PUBLIC CANADIEN TORONTO, 17 sept. 2024 (GLOBE NEWSWIRE) -- (Nasdaq : BCRX) a annoncé aujourd’hui l’aboutissement des négociations avec l’Alliance pharmaceutique pancanadienne (APP) au sujet de PrORLADEYOMD (bérotralstat), un médicament oral à prise uniquotidienne homologué au Canada pour la prévention de routine des crises d’angio-œdème héréditaire che...
- Jonathan Moreland
PAYC PAYCOM SOFTWARE INC.
I3N CHART INDUSTRIES INC.
BEN FRANKLIN RESOURCES INC.
HTLD HEARTLAND EXPRESS INC.
RIGN TRANSOCEAN LTD.
CLAR CLARUS CORPORATION
STIM STIMSONITE CORP
U UNITY SOFTWARE INC.
GRNT GRANIT SKOPKE
TDUP THREDUP INC.
GNLX GENELUX CORP
BTSG BRIGHTSPRING HEALTH SERVICES INC.
AOI Announces Quantum18™ Product Series to Simplify Technology Upgrade...
AOI Announces Quantum18™ Product Series to Simplify Technology Upgrades and Support Motorola Housings Integrations Company to showcase Quantum18™ products, including 1.8GHz node and amplifiers at upcoming SCTE® Cable-Tec Expo® SUGAR LAND, Texas, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Applied Optoelectronics Inc. (“AOI”) (NASDAQ: AAOI), a leading provider of fiber-optic access network products for internet datacenter, cable broadband, telecom and fiber-to-the-home (FTTH) markets, announces its latest Quantum18™ product series, designed for cable operators to upgrade to 1.8GHz and integrate i...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.